Trials / Active Not Recruiting
Active Not RecruitingNCT04048655
Reversal of Neuromuscular Blockade During the General Anaesthesia
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Tampere University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
There are individual reports indicating that after the reversal of nondepolarizing neuromuscular blockade with neostigmine, some patients starts to relax spontaneously again after the tof ratio has already recovered to the safe level (\>90%). The mechanism behind this in not well understood, and the incidence of the phenomenon is unclear. In this study the investigators try to determine the incidence of the aforementioned postrecovery relaxation.
Detailed description
There are individual reports indicating that after the reversal of nondepolarizing neuromuscular blockade with neostigmine, some patients start to relax spontaneously again after the tof ratio has already recovered to the safe level (90%). The mechanism behind this in not well understood and the incidence of the phenomenon is unclear. The aim of this study is to monitor the reversal of rocuronium induced neuromuscular blockade with neostigmine. The neuromuscular blockade is monitored with train of four stimulations using electromyography. After the reversal agent is given and train of four ratio has recovered to the level of 90%, the neuromuscular blockade is monitored another 30min to see if tof ratio starts to spontaneously fall again under the 90%. If aforementioned postrecovery relaxation happens, the investigators are able to calculate the incidence of the phenomenon.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Neostigmine, Combinations | All patients have neostigmine induced recovery of neuromuscular block. |
Timeline
- Start date
- 2020-04-08
- Primary completion
- 2025-09-01
- Completion
- 2025-12-31
- First posted
- 2019-08-07
- Last updated
- 2025-09-16
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT04048655. Inclusion in this directory is not an endorsement.